5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.12▼ | 1.12▼ | 1.12▼ | 1.12▲ | 1.13▼ |
MA10 | 1.12▼ | 1.13▼ | 1.13▼ | 1.10▲ | 1.14▼ |
MA20 | 1.12▼ | 1.13▼ | 1.12▼ | 1.12▼ | 0.94▲ |
MA50 | 1.13▼ | 1.12▲ | 1.11▲ | 1.13▼ | 0.88▲ |
MA100 | 1.13▼ | 1.10▲ | 1.11▲ | 0.92▲ | 1.32▼ |
MA200 | 1.12▲ | 1.11▲ | 1.12▼ | 0.78▲ | 1.86▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.002▼ | -0.002▼ | -0.002▼ | 0.025▲ |
RSI | 43.441▼ | 47.007▼ | 50.572▲ | 50.982▲ | 56.681▲ |
STOCH | 16.667▼ | 20.000 | 15.598▼ | 53.182 | 51.188 |
WILL %R | -100.000▼ | -83.333▼ | -92.308▼ | -47.059 | -38.994 |
CCI | -58.333 | -94.363 | -84.848 | 46.788 | 44.499 |
Thursday, September 11, 2025 05:47 AM
Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic ...
|
Monday, September 08, 2025 05:41 AM
Data obtained from ongoing third-party funded, investigator-sponsored trials have been submitted in effort to address the December 2024 complete response letter Company seeks alignment on reasonable ...
|
Saturday, September 06, 2025 12:09 PM
Detailed price information for Lexicon Pharmaceutcl (LXRX-Q) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 1.135 | 1.135 | 1.12 | 1.12 | 213,772 |
15/09/25 | 1.17 | 1.189 | 1.11 | 1.12 | 1,715,466 |
12/09/25 | 1.10 | 1.15 | 1.10 | 1.15 | 1,688,007 |
11/09/25 | 1.08 | 1.131 | 1.08 | 1.11 | 1,908,707 |
10/09/25 | 1.13 | 1.13 | 1.08 | 1.08 | 1,605,992 |
09/09/25 | 1.07 | 1.15 | 1.06 | 1.13 | 2,263,308 |
08/09/25 | 1.09 | 1.0993 | 1.05 | 1.08 | 1,082,655 |
05/09/25 | 1.06 | 1.11 | 1.05 | 1.09 | 1,783,998 |
04/09/25 | 1.08 | 1.09 | 1.03 | 1.07 | 1,522,847 |
03/09/25 | 1.13 | 1.13 | 1.08 | 1.08 | 1,186,367 |
|
|
||||
|
|
||||
|
|